Revenue: The sum of all revenue fields included for a company's operating activities.
Globeimmune, Inc. (GBIM) had Revenue of $6.46M for the most recently reported fiscal year, ending 2015-12-31.
Income Statement Financials | |
Revenue |
$6.46M |
$-2.77M |
|
$2.65M |
|
$3.81M |
|
$9.22M |
|
$-2.77M |
|
-- |
|
$-2.77M |
|
$-2.77M |
|
$-2.77M |
|
$-2.77M |
|
$-2.77M |
|
$-2.77M |
|
$-2.77M |
|
$-2.58M |
|
5.75M |
|
5.75M |
|
$-0.48 |
|
$-0.48 |
|
Balance Sheet Financials | |
$11.09M |
|
$0.21M |
|
$0.42M |
|
$11.51M |
|
$4.23M |
|
-- |
|
$4.29M |
|
$8.52M |
|
$2.99M |
|
$2.99M |
|
$2.99M |
|
5.75M |
|
Cash Flow Statement Financials | |
$-7.13M |
|
$0.22M |
|
-- |
|
$16.81M |
|
$9.90M |
|
$-6.91M |
|
$0.15M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
2.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
58.99% |
|
-42.85% |
|
-42.85% |
|
-39.95% |
|
-42.85% |
|
-42.85% |
|
$-6.91M |
|
-- |
|
-- |
|
-- |
|
0.56 |
|
-- |
|
-- |
|
-- |
|
-92.59% |
|
-92.59% |
|
-24.05% |
|
-92.59% |
|
$0.52 |
|
$-1.20 |
|
$-1.24 |